XILLIX FDA APPROVED Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: hsg who wrote (441)	7/19/1999 12:48:00 PM
From: Edward W. Richmond	Read Replies (1) of 572

hsg, The Blue Book of Undervalued Stocks includes XLX as a stock that is over sold. Their analysis is very positive. However, a major cash crunch can decimate a company. Hopefully for all of us, this won't happen to XLX. The Miravant deal brought us enough money to buy considerable time. I'm not sure how we will handle our need for financing in a year. Having had two stocks run out of cash, has left me gun shy. It both instances it hasn't been pretty. Regards, Ed P.S. Do you remember the Midland Walwyn analyst recommending the selling of QLT Phototherapeutics and the buying of Xillix?. I wonder if he is still employed.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next